Skip to main content

Table 9 Bivariate analysis: clinical characteristics and mortality

From: Serologic and urinary characteristics of laboratory-confirmed genitourinary tuberculosis at a tertiary hospital in the Philippines

Characteristic Category Mortality p value
Survived Expired
Count Row % Count Row %
Gender Male 48 92.3 4 7.7 1.000
Female 55 91.7 5 8.3
Age 0 months to 1 year 0 0.0 1 100.0 <0.001
1–5 years 0 0.0 2 100.0
6–10 years 4 100.0 0 0.0
11–18 years 17 94.4 1 5.6
19–29 years 19 90.5 2 9.5
30–49 years 33 94.3 2 5.7
50–69 years 26 96.3 1 3.7
≥ 70 years 4 100.0 0 0.0
Marital status Single/widowed 63 91.3 6 8.7 1.000
Married 40 93.0 3 7.0
Occupation Employed 18 94.7 1 5.3 0.394
Unemployed 54 93.1 4 6.9
Not applicable 22 84.6 4 15.4
Unspecified 9 100.0 0 0.0
Location City 55 91.7 5 8.3 0.834
Province 44 91.7 4 8.3
Unspecified 4 100.0 0 0.0
Co-morbidity Yes 50 94.3 3 5.7 0.495
No 53 89.8 6 10.2
Diabetes mellitus Yes 5 100.0 0 0.0 1.000
No 98 91.6 9 8.4
Hypertension Yes 13 100.0 0 0.0 0.595
No 90 90.9 9 9.1
Chronic kidney disease Yes 4 80.0 1 20.0 0.347
No 99 92.5 8 7.5
History of urolithiasis Yes 8 100.0 0 0.0 1.000
No 95 91.3 9 8.7
Malignancy Yes 1 100.0 0 0.0 1.000
No 102 91.9 9 8.1
HIV/AIDS Yes 10 83.3 2 16.7 0.247
No 93 93.0 7 7.0
Steroid use Yes 9 100.0 0 0.0 1.000
No 94 91.3 9 8.7
Systemic lupus erythematosus Yes 8 100.0 0 0.0 1.000
No 95 91.3 9 8.7
Nephrotic syndrome Yes 1 100.0 0 0.0 1.000
No 102 91.9 9 8.1
Cerebrovascular disease Yes 1 100.0 0 0.0 1.000
No 102 91.9 9 8.1
Coronary artery disease No 103 92.0 9 8.0 No test*
Heart failure Yes 2 100.0 0 0.0 1.000
No 101 91.8 9 8.2
COPD Yes 1 100.0 0 0.0 1.000
No 102 91.9 9 8.1
Bronchial asthma Yes 2 100.0 0 0.0 1.000
No 101 91.8 9 8.2
Spina bifida No 103 92.0 9 8.0 No test*
RTA Type 1 Yes 1 100.0 0 0.0 1.000
No 102 91.9 9 8.1
Previous TB Yes 14 100.0 0 0.0 0.599
No 89 90.8 9 9.2
Other organ involvement of TB Yes 57 89.1 7 10.9 0.296
No 46 95.8 2 4.2
Pulmonary TB Yes 50 87.7 7 12.3 0.162
No 53 96.4 2 3.6
Gastrointestinal TB Yes 24 85.7 4 14.3 0.224
No 79 94.0 5 6.0
Abdominopelvic TB Yes 11 100.0 0 0.0 0.595
No 92 91.1 9 8.9
CNS TB Yes 6 85.7 1 14.3 0.453
No 97 92.4 8 7.6
Bone TB Yes 3 75.0 1 25.0 0.288
No 100 92.6 8 7.4
Cutaneous/Wound TB Yes 3 100.0 0 0.0 1.000
No 100 91.7 9 8.3
TB Adenitis Yes 7 87.5 1 12.5 0.500
No 96 92.3 8 7.7
Ear TB Yes 1 50.0 1 50.0 0.155
No 102 92.7 8 7.3
Psoas TB Yes 1 50.0 1 50.0 0.155
No 102 92.7 8 7.3
Dysuria Yes 7 100.0 0 0.0 1.000
No 82 90.1 9 9.9
Hematuria Yes 7 77.8 2 22.2 0.192
No 82 92.1 7 7.9
Urinary retention Yes 1 100.0 0 0.0 1.000
No 88 90.7 9 9.3
Flank pain Yes 11 100.0 0 0.0 0.592
No 78 89.7 9 10.3
Inguinal pain Yes 1 100.0 0 0.0 1.000
No 88 90.7 9 9.3
Umbilical discharge Yes 3 100.0 0 0.0 1.000
No 86 90.5 9 9.5
Fistula (uretero-cutaneous fistula) Yes 1 100.0 0 0.0 1.000
No 88 90.7 9 9.3
Scrotal discharge Yes 1 100.0 0 0.0 1.000
No 88 90.7 9 9.3
Double J stent reinsertion Yes 1 100.0 0 0.0 1.000
No 88 90.7 9 9.3
Pedal edema Yes 4 100.0 0 0.0 1.000
No 85 90.4 9 9.6
Fever Yes 7 100.0 0 0.0 1.000
No 82 90.1 9 9.9
Weakness Yes 14 93.3 1 6.7 1.000
No 75 90.4 8 9.6
Abdominal pain Yes 6 75.0 2 25.0 0.157
No 83 92.2 7 7.8
Abdominal/pelvic mass on diagnostic Yes 4 100.0 0 0.0 1.000
No 85 90.4 9 9.6
Vaginal bleeding Yes 2 100.0 0 0.0 1.000
No 87 90.6 9 9.4
Difficulty of breathing Yes 10 83.3 2 16.7 0.303
No 79 91.9 7 8.1
Others Yes 9 81.8 2 18.2 0.266
No 80 92.0 7 8.0
  1. Bold values indicate statistically significant differences
  2. *No test was done since all patients were classified under the No category
  3. COPD chronic obstructive pulmonary disease, HIV/AIDS human immunodeficiency virus or acquired immunodeficiency syndrome, RTA Type 1 renal tubular acidosis Type 1, TB tuberculosis, y year